MedTrace Logo

Brief ROC Training Effects on Alcohol Drinking

NCT03928626 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2024-02-28

No results posted yet for this study

Summary

The goal of the proposed study is to examine whether a single session of training in regulation of craving (ROC-T) affects alcohol drinking. The study will consist of (1) a basic screening (phone and/or online) and an in-person visit, to determine eligibility and conduct pre-intervention baseline assessments; (2) a training (ROC-T) visit, (3) a post-intervention assessment visit, and (4) 1-2 phone/online follow-up assessments.

The study will take up to 10 hours of the participants' time.

Conditions

  • Binge Drinking
  • Heavy Drinking
  • Young Adult
  • Heavy Drinker
  • Alcohol Drinking
  • Alcohol Drinking in College
  • Drinking Behavior
  • Drunkenness
  • Drinking Excessive
  • Drinking Problem
  • Drink Too Much
  • College Drinking

Interventions

BEHAVIORAL

Regulation of craving

Participants in the ROC-T condition will be trained to use a strategy that instructs them to think of the negative outcomes associated with alcohol drinking while looking at alcohol-related images.

BEHAVIORAL

Control (NO REGULATION)

In the CONTROL condition, participants would simply observe non-alcohol-related images and allow natural responses to come

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Uri Berger, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-10
Primary Completion
2020-03-15
Completion
2020-03-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03928626 on ClinicalTrials.gov